Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

Norpace Retard (Disopyramide Base 150mg) Tablets (32754)

ARTG ID

32754

ARTG Name

Norpace Retard (Disopyramide Base 150mg) Tablets

Sponsor

Proqualix Pty Ltd - in Administration

ARTG Date

October 28, 1991

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Listed - Exempt

Sponsor Information

Sponsor Name

Proqualix Pty Ltd - in Administration

Sponsor Item Name

proqualix pty ltd - in administration

Active Ingredients

Ingredient Name

disopyramide phosphate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy